Published in J Cell Sci on August 09, 2005
In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells (2009) 1.46
Nanotopographical control of stem cell differentiation. J Tissue Eng (2010) 1.38
Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics (2008) 1.23
Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol (2008) 1.18
Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng Part A (2009) 1.06
Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS One (2011) 0.96
MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells. BMC Med Genomics (2011) 0.96
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. Endocr Relat Cancer (2013) 0.96
Generation of neural stem cell-like cells from bone marrow-derived human mesenchymal stem cells. Neurol Res (2011) 0.94
Neurotrophic features of human adipose tissue-derived stromal cells: in vitro and in vivo studies. J Biomed Biotechnol (2011) 0.92
Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res (2014) 0.89
A distinct role for secreted fibroblast growth factor-binding proteins in development. Proc Natl Acad Sci U S A (2009) 0.89
Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing. Expert Opin Biol Ther (2011) 0.87
Neural crest stem cells from dental tissues: a new hope for dental and neural regeneration. Stem Cells Int (2012) 0.85
Targeting pericytes for angiogenic therapies. Microcirculation (2014) 0.84
Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int (2013) 0.83
Therapeutic potential of mesenchymal stem cells for oral and systemic diseases. Dent Clin North Am (2012) 0.81
A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. J Diabetes Metab Disord (2014) 0.79
Evaluation of biodegradable electric conductive tube-guides and mesenchymal stem cells. World J Stem Cells (2015) 0.79
Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations. Histochem Cell Biol (2010) 0.78
Promoting nerve regeneration in a neurotmesis rat model using poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly: in vitro and in vivo analysis. Biomed Res Int (2014) 0.78
Peripheral Nerve Regeneration by Secretomes of Stem Cells from Human Exfoliated Deciduous Teeth. Stem Cells Dev (2015) 0.78
Differentiation of rhesus adipose stem cells into dopaminergic neurons. Neural Regen Res (2012) 0.77
Cell phenotypes in human amniotic fluid. Acta Naturae (2009) 0.77
Reprogramming cells for brain repair. Brain Sci (2013) 0.76
Cell replacement therapy for central nervous system diseases. Neural Regen Res (2015) 0.76
Origin and regenerative potential of vertebrate mechanoreceptor-associated stem cells. Anat Res Int (2012) 0.75
Autocrine fibronectin from differentiating mesenchymal stem cells induces the neurite elongation in vitro and promotes nerve fiber regeneration in transected spinal cord injury. J Biomed Mater Res A (2016) 0.75
Identification of neuron-related genes for cell therapy of neurological disorders by network analysis. J Zhejiang Univ Sci B (2017) 0.75
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells (2009) 3.54
Glial cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci (2002) 3.37
Draft Genome Sequence of Lysobacter capsici AZ78, a Bacterium Antagonistic to Plant-Pathogenic Oomycetes. Genome Announc (2014) 1.77
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis (2007) 1.56
Radial glial cells as neuronal precursors: a new perspective on the correlation of morphology and lineage restriction in the developing cerebral cortex of mice. Brain Res Bull (2002) 1.53
"Destemming" cancer stem cells. J Natl Cancer Inst (2007) 1.51
Prospective isolation of functionally distinct radial glial subtypes--lineage and transcriptome analysis. Mol Cell Neurosci (2008) 1.25
Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem (2002) 1.22
Recent insights into PDGF-induced gliomagenesis. Brain Pathol (2009) 1.15
Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. Matrix Biol (2002) 1.14
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol (2002) 1.08
Proteoglycan control of cell movement during wound healing and cancer spreading. Matrix Biol (2005) 1.06
Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia (2008) 1.03
PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer (2009) 1.03
A nick-sensing DNA 3'-repair enzyme from Arabidopsis. J Biol Chem (2002) 1.03
COLOMBOS v2.0: an ever expanding collection of bacterial expression compendia. Nucleic Acids Res (2013) 1.02
Benchmarking protein classification algorithms via supervised cross-validation. J Biochem Biophys Methods (2007) 1.01
The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J (2004) 1.01
Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma. Cancer Res (2014) 1.00
Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J Transl Med (2012) 0.99
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells. Am J Physiol Lung Cell Mol Physiol (2012) 0.98
Sonic hedgehog regulates the position of the trigeminal ganglia. Dev Biol (2003) 0.94
MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr) (2011) 0.93
Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma. Mol Ther (2012) 0.93
Six3 controls the neural progenitor status in the murine CNS. Cereb Cortex (2007) 0.93
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol (2005) 0.92
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. J Cell Physiol (2006) 0.92
Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid (2011) 0.92
NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients. J Orthop Res (2009) 0.91
Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis. Neurobiol Dis (2011) 0.89
The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment. Neoplasia (2010) 0.88
Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. Angiogenesis (2012) 0.88
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. J Mol Cell Biol (2013) 0.87
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. Int J Oncol (2003) 0.86
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol (2012) 0.86
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development. Development (2006) 0.86
Fluorescence-based assays for in vitro analysis of cell adhesion and migration. Methods Mol Biol (2009) 0.86
Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease. Ann N Y Acad Sci (2012) 0.86
Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem (2012) 0.85
Approaching the proteoglycome: molecular interactions of proteoglycans and their functional output. Macromol Biosci (2006) 0.85
Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma. Int J Cancer (2012) 0.85
Antithetic roles of proteoglycans in cancer. Cell Mol Life Sci (2011) 0.85
Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth. Matrix Biol (2010) 0.84
Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res (2007) 0.84
Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. Br J Pharmacol (2012) 0.83
Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex. J Cell Mol Med (2009) 0.83
A novel collection of snRNA-like promoters with tissue-specific transcription properties. Int J Mol Sci (2012) 0.83
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells. Int J Oncol (2005) 0.82
Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. FASEB J (2002) 0.82
PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2. BMC Cancer (2010) 0.81
Pitfalling in nanomedical targeting of melanoma: a 'clinical' case of misdelivered RNAi. Pigment Cell Melanoma Res (2011) 0.80
Preferential locomotion of leukemic cells towards laminin isoforms 8 and 10. Matrix Biol (2003) 0.79
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. Matrix Biol (2007) 0.79
Identification and gene expression of versican during early development of Xenopus. Int J Dev Biol (2008) 0.78
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance. J Transl Med (2006) 0.78
Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ. J Pathol (2003) 0.78
Proteoglycans in the control of tumor growth and metastasis formation. Connect Tissue Res (2008) 0.78
Regulated gene expression of hyaluronan synthases during Xenopus laevis development. Gene Expr Patterns (2004) 0.78
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. J Immunol Methods (2005) 0.76
Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas. Am J Pathol (2003) 0.76
Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model. Int J Mol Sci (2012) 0.75
Platelet derived growth factor B gene expression in the Xenopus laevis developing central nervous system. Int J Dev Biol (2016) 0.75